196 related articles for article (PubMed ID: 16712790)
1. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
[TBL] [Abstract][Full Text] [Related]
3. Alpha-bulnesene, a PAF inhibitor isolated from the essential oil of Pogostemon cablin.
Tsai YC; Hsu HC; Yang WC; Tsai WJ; Chen CC; Watanabe T
Fitoterapia; 2007 Jan; 78(1):7-11. PubMed ID: 17107759
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
Herbert JM; Laplace MC; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
8. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
[TBL] [Abstract][Full Text] [Related]
10. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.
Han BH; Yang HO; Kang YH; Suh DY; Go HJ; Song WJ; Kim YC; Park MK
J Med Chem; 1998 Jul; 41(14):2626-30. PubMed ID: 9651167
[TBL] [Abstract][Full Text] [Related]
11. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
12. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
13. Bakkenolide G, a natural PAF-receptor antagonist.
Liao CH; Ko FN; Wu TS; Teng CM
J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
[TBL] [Abstract][Full Text] [Related]
14. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum.
Nordin N; Jalil J; Jantan I; Murad S
Pharm Biol; 2012 Mar; 50(3):284-90. PubMed ID: 22103812
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding.
Jantan I; Pisar MM; Idris MS; Taher M; Ali RM
Planta Med; 2002 Dec; 68(12):1133-4. PubMed ID: 12494345
[TBL] [Abstract][Full Text] [Related]
18. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E₂ and Thromboxane B₂ production and platelet activating factor receptor binding.
Saadawi S; Jalil J; Jasamai M; Jantan I
Molecules; 2012 Apr; 17(5):4824-35. PubMed ID: 22538486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
